A Single Ascending Dose Study To Evaluate Safety And Pharmacokinetics Of Compound PF-06648671 In Healthy Subjects
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This is first in human (FIH), double-blind, sponsor open, placebo-control trial to examine
the safety, tolerability, pharmacokinetics and pharmacodynamics following a single ascending
doses of PF-06648671 in healthy subjects.